SEOLREIM · JOURNAL
Skinvive Results, Bumps, and Side Effects: Differences from Hydrating Injections and Profhilo
Full professional English translation completed and self-reviewed against the Korean source; numerical tokens and medical cautions preserved; separate medical review of this translation is pending. Translation updated: 2026-10-28.

Skinvive is an injectable that places microdroplets of cross-linked hyaluronic acid within the dermis to improve smoothness of adult cheek skin. Its U.S. FDA approval is also limited to cheek-skin smoothness; it is not a filler designed to create substantial volume or an injection guaranteed to hydrate the entire face. In addition to bumps, bruising, and swelling, the risks of nodules, infection, and rare vascular occlusion associated with all filler-type injectables must be considered.
Definition, effects and precautions at a glance
| Category | What to check |
|---|---|
| Ingredient and method | Intradermal microdroplet injection of cross-linked HA |
| Main goal | Improves smoothness and fine texture of adult cheek skin |
| Recovery | Small injection marks, bumps, and swelling for several days; bruising may last 1–2 weeks |
| Limitations | Does not directly correct substantial volume loss, severe laxity, or scars |
| Main risks | Infection, nodules, persistent swelling, and rare vascular occlusion |
Definition and mechanism
Hyaluronic acid is a water-attracting polysaccharide whose behavior in tissue varies with the degree of cross-linking, particle characteristics, and injection layer. Skinvive is designed to improve surface smoothness through intradermal microdistribution rather than to restore volume, but even with the same product name, the total amount, interval, injection depth, and approved indications must be checked. If skin dryness is caused by barrier damage or dermatitis, treating the cause takes priority over injection.
Potential benefits and limitations
Clinical trials and the FDA review reported improvement in measures of cheek-skin smoothness. Initial swelling must be distinguished from actual texture changes and assessed after several weeks; results and duration vary with skin thickness, lifestyle, and injected amount. The treatment does not resolve deep wrinkles, volume loss, severe laxity, or acne scars all at once.
Who may be suitable and when to avoid treatment
Appropriate candidates are adults whose main concerns are subtle roughness and superficial fine lines and who can accommodate injection marks. Pregnancy or breastfeeding, active infection, dermatitis or herpes, bleeding disorders, severe allergies, previous filler nodules or vascular complications, and recent fillers, threads, or laser treatment must be disclosed. Under U.S. approval, the cheek indication applies to adults aged 21 or older; Korean approval must be confirmed separately.
Procedure and expected recovery period
The doctor distinguishes among barrier condition, skin thickness, pores, volume, laxity, and existing injected materials, then records the authentic product name, lot number, total amount, injection layer, and excluded areas. Injection marks, bumps, and swelling generally last several days, while bruising may last 1–2 weeks. Patients should receive guidance about when to resume alcohol, saunas, strenuous exercise, and makeup. Allowing time to identify adverse reactions is safer than scheduling treatment immediately before returning home.

Side effects, contraindications and warning signs
In addition to pain, bruising, swelling, itching, and firmness, possible complications include infection, prolonged swelling, nodules, herpes reactivation, and surface irregularity. Rarely, vascular occlusion can lead to skin necrosis or visual symptoms. Severe pain, pale or mottled skin, blurred or double vision, or rapidly worsening swelling requires immediate emergency evaluation.
Differences Among Skinvive, Hydrating Injections, Profhilo, and HA Fillers
| Method | Main goal | Key differences and precautions |
|---|---|---|
| Skinvive | Cheek-skin smoothness and fine texture | Cross-linked HA microdroplets; confirm approved areas and total amount |
| Skin hydration injections | Hydration and texture care through microinjections of HA | Products vary in mixed ingredients and cross-linking |
| Profhilo | Concept of bio-remodeling with diffusible HA | Differences in injection points, formulation, and approved indications |
| HA filler | Volume and contour in selected areas | Vascular occlusion and overcorrection; injection into deeper layers may be possible |
Medical Q&A
Q. Is Skinvive a filler?
A. It belongs to the HA injectable category, but its main purpose is intradermal microinjection and skin smoothness rather than substantial volume.
Q. Can it be injected across the entire face?
A. Approved indications and skin thickness differ by area, so use outside the cheeks must be assessed against the product label and the clinician’s judgment.
Q. How long do the bumps last?
A. They generally subside within several days, but persistent, red, or painful bumps require evaluation for infection or nodules.
References
The U.S. FDA announcement of Skinvive approval (https://www.fda.gov/medical-devices/recently-approved-devices/skinvive-juvederm-p110033s059) presents the 2023-7 indication and clinical information for improving adult cheek-skin smoothness. The original FDA PMA document (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P110033S059) and FDA guidance on dermal-filler risks (https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/dermal-fillers-soft-tissue-fillers) were also consulted. Korean approval takes precedence.
SEOLREIM's principle of consultation and treatment directly by the clinic director
SEOLREIM Clinic does not choose an injectable based only on the term “glass skin.” The doctor personally distinguishes among the skin barrier, fine texture, volume, pores, and laxity, then compares only 2–3 appropriate options among signature skin boosters—such as Skinvive, hydrating injections, Rejuran, Juvelook, and Profhilo—using products actually available at the clinic. The doctor performs the treatment directly according to SEOLREIM’s principles of authentic products, correct quantities, and attentive care.
Information for international visitors
Visitors searching for “SKINVIVE Korea” or “skin booster Korea” should confirm the exact product name, lot number, total amount, approved treatment areas, expected bumps, and how to contact the clinic about nodules or vascular symptoms after returning home. SEOLREIM Clinic is on the 11th floor of the Gangnam 8258 Building, about 1 minute from Exit 3 of Gangnam Station. Appointments can be made through the website’s KakaoTalk consultation, Naver booking, or telephone channels. International visitors comparing information on a Gangnam skin clinic, Seoul skin clinic, Gangnam Station skin clinic, or Korean skin clinic should prepare their passport, allergy information, medication list, recent treatment records, and departure schedule, and should confirm available consultation languages and the scope of interpretation support before booking. Depending on the examination findings, same-day treatment may not be possible, or follow-up after returning home may be necessary.
Author, reviewer, publication date and update date
Written by: SEOLREIM Content Editor / Medical review: Completed / Review confirmation date: 2026-10-23 / Publication date: 2026-09-29 / Updated: 2026-10-27. This is general medical information and does not replace individual diagnosis or a treatment prescription.
SEOLREIM · GANGNAM, SEOUL
Discuss Skin Treatments in Seoul with Seolreim Clinic.
Seolreim Clinic provides doctor-led consultation and treatment, following its principles of genuine products, accurate quantities and attentive care.
Tell us your treatment interests, skin concerns, dates in Korea and preferred consultation language. Confirm treatment suitability, recovery plans and language support before booking.
